Quick Takeaways
- James C. Momtazee has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $5,627,936.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow James C. Momtazee and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Director | $3,122,427 | 20 Jun 2025 | ||
| ROIV | Roivant Sciences Ltd. | Director | $2,505,509 | 20 Jan 2026 | ||
| MAAC | Montes Archimedes Acquisition Corp | Chief Executive Officer, Director, 10%+ Owner | 30 Sep 2021 | |||
| PRAH | PRA Health Sciences, Inc. | Director | 01 Jul 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|